J. Goldman & Co LP - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2021$439,000
-66.9%
23,227
-67.5%
0.02%
-57.7%
Q2 2021$1,328,000
+19.3%
71,440
+46.0%
0.05%
+44.4%
Q1 2021$1,113,000
-64.6%
48,916
-66.2%
0.04%
-77.5%
Q4 2020$3,140,000144,6160.16%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders